C
Cyclacel Pharmaceuticals D
D
CYCCP
6.85000
USD
-0.45
(-6.16%)
Market Closed
Volume
0
EPS
0
Div Yield
0
P/E
0
Market Cap
2,296,620
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Cyclacel Pharmaceuticals
Sector: Healthcare
Industry: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.